BNP Paribas Financial Markets
TBRA

BNP Paribas Financial Markets’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

BNP Paribas Financial Markets’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-75,594
Closed -$3M – 4265
2016
Q3 		$3M Buy
75,594
+75,252
+22,004% +$840K 0.01% 591
2016
Q2 		$4.3K Buy
+342
New +$3.19K ﹤0.01% 3333
2016
Q1 		– Sell
-492
Closed -$4.94K – 3458
2015
Q4 		$4.94K Sell
492
-6
-1% -$62 ﹤0.01% 3455
2015
Q3 		$4.81K Buy
+498
New +$6.99K ﹤0.01% 3485
2015
Q2 		– Sell
-42
Closed -$458 – 3703
2015
Q1 		$458 Buy
+42
New +$451 ﹤0.01% 3576
2014
Q4 		– Sell
-33
Closed -$340 – 3862
2014
Q3 		$340 Buy
+33
New +$652 ﹤0.01% 4035

BNP Paribas Financial Markets's TBRA Position: Q4 2016 in Review

BNP Paribas Financial Markets sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 75,594 shares — an estimated $3M sold.

BNP Paribas Financial Markets first reported a position in TBRA in Q3 2014 and held it in 6 quarters. The position peaked at $3M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

  • BNP Paribas Financial Markets reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 75,594 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $3M.
  • BNP Paribas Financial Markets first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2014 and held it in 6 quarters.
  • BNP Paribas Financial Markets's Tobira Therapeutics, Inc. Common Stock position peaked at $3M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2016, filed 14 Feb 2017.